All News

Health disparities likely exist in youth epilepsy but few studies have focused on these disparities.

Texas Oncology's Travis Brewer, vice president of payer relations, discusses how collaboration between primary care providers and oncologists can improve population health outcomes by focusing on payer initiatives and strategies.

Residents of homeless shelters were tested for respiratory syncytial virus (RSV) and influenza, which were found to have similar prevalence in the population.

The treatment is the first approved by the FDA to treat the 2 most common subtypes of generalized myasthenia gravis.

Four people in Florida and 1 person in Texas were exposed to malaria; late revisions could counter a pending lawsuit to end abortion restrictions; about 2000 nurses in Texas and Kansas plan to strike.

The patient was put on chemotherapy, but then underwent surgical resection following an accident at home.

Healthy sleep before being infected with SARS-CoV-2 infection and before and during the COVID-19 pandemic might protect against post–COVID-19 condition, or long COVID.

Investigators say their data show the importance of vaccination and antibiotic stewardship programs.

Late-breaking results of the COORDINATE-Diabetes trial were presented today at the American Diabetes Association (ADA) 83rd Scientific Sessions in San Diego, California.

Telemedicine is effective to diagnose and treat various dermatologic conditions in the pediatric population.

Early detection of focal epilepsy may reduce the amount of motor vehicle accidents caused by seizures while driving.

A new study estimated that 9.60 million people are living with diabetic retinopathy and 1.84 million people are living with vision-threatening diabetic retinopathy in the United States.

Black veterans continue to encounter benefits disparities; health workers feel capable of handling future surges after the pandemic; the COVAX initiative aims to redirect remaining vaccine spending

Latina women at risk of hereditary breast and ovarian cancer are less likely to be referred for genetic counseling and testing.

On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the June 2023 issue of The American Journal of Managed Care® about how employers and their employees are utilizing direct-to-consumer telehealth to reduce the cost of care.

The infrastructure also provides a blueprint for similar initiatives in other rare diseases.

A new review outlines strategies that may help reduce the risk of severe cytokine release syndrome (CRS) for patients treated with immunotherapy.

The Act4Biosimilars Action Plan seeks to increase biosimilar adoption by at least 30 percentage points in 30-plus countries by 2030.

A new model produces information that can lead to individual providers identifying women who may need more targeted and more frequent HIV testing or be good candidates for preexposure prophylaxis.

The study was conducted to provide insight into real-world Bruton tyrosine kinase (BTK) inhibitor treatment patterns in mantle cell lymphoma, as current data are limited.

Since 1930, there have been fewer than 1000 cases of the disease reported around the world.

Matthew Mansh, MD, FAAD, discusses inequities faced by transgender and gender-diverse patient populations.

The advent of gene therapies, which can target specific variants, means pinpointing the genetic roots of each patient’s disease has taken on new importance, researchers said.

A recent review highlighted a selection of emerging therapies and advances in sickle cell disease (SCD) that focus on renal manifestations.

The model has potential to assist integrated delivery network health care providers through early identification of patients with pulmonary arterial hypertension (PAH), a rare but fast-progressing condition.

New findings show that VX-880, a stem cell-derived islet cell therapy, can restore endogenous insulin secretion and improve glycemic control in people living with type 1 diabetes (T1D).

The cross-sectional study of 260 people with epilepsy collected data between October and December 2020, months following the onset of the pandemic in the United States.

"Our research is unique in its attempt to describe a high-need, high-cost patient population who might benefit from increased monitoring or intervention,"Ann Cameron, PhD, says.

A recent study found that depressive symptoms improved among patients with severe asthma who responded to monoclonal antibody (mAb) therapy, but baseline depression symptoms were associated with lower therapy response rates.

Epcoritamab has been added to the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology for B-cell Lymphomas in the third- or later-line setting for the treatment of patients with diffuse large B-cell lymphoma.